A COMPARATIVE ANALYTICAL STUDY OF MATERNAL MORBIDITY AND MORTALITY INDICATORS BETWEEN PLACENTA ACCRETA SPECTRUM (PAS) AND NORMAL PLACENTATION DURING CAESAREAN SECTION

Introduction: The Placenta Accreta Spectrum (PAS) has emerged as a complex and increasingly prevalent condition, presenting formidable challenges in the field of obstetrics. PAS refers to a range of pathological conditions characterized by abnormal placental attachment to the uterine wall, leading to potentially life-threatening complications during pregnancy and childbirth. This condition has garnered significant attention from researchers, clinicians, and healthcare providers due to its rising incidence and the critical management decisions it demands. Methods: This was a Case-Control study which was conducted at the department of Obstetrics and Gynecology in a tertiary care referral center in Akola, India between January 2020, and June 2021, over a period of 18 months (about 1 and a half years). Sample size calculation were considered based on the incidence of Placenta Accreta Spectrum as outlined by the study done by Wu S et al [4]. Result: As noted by earlier studies, our study also found an increase in the overall morbidity of the patients of Placenta Accreta Spectrum disorders over patients with normal placentation, during and after caesarean section. Conclusion: Placenta Accreta Spectrum leads to significant maternal morbidity and mortality compared to normal placentation at caesarean section, as established by and increased rate of Obstetric Hysterectomies, longer operating times, increased need for blood and blood products, longer ICU stay, and increased rates of postpartum fever.